Finding a trustworthy Mounjaro supplier in the UK: what actually matters

The biggest myth: a lower price means you've found a better supplier

This is the misconception that puts the most people at risk. A supplier offering Mounjaro at a noticeably lower price than the market range isn't passing on savings from a savvier buying deal — the licensed UK wholesale price for tirzepatide doesn't work that way. Since Eli Lilly raised its UK list price in September 2025, the highest-dose pen's list price rose to around £330; typical private prices since then have ranged roughly £149 to £375 per month depending on dose and provider, as widely reported at the time. A supplier sitting far below that floor should trigger a question, not a purchase.

The MHRA has been explicit on this point. Fake tirzepatide pens have been recovered from illegal UK operations, some containing the wrong active substance entirely. Around 20 million doses of illegally traded weight-loss medicines (approximately £45m in estimated street value) were seized in 2025 alone, and a counterfeit-production site was shut down in Northampton that October. You can report a suspect seller via the MHRA Yellow Card scheme if you come across one. A bargain that turns out to be a fake pen isn't a bargain; it's a health risk.

Price context is genuinely useful to know, and a full breakdown of Mounjaro costs in the UK covers what legitimate pricing includes and why headline figures can mislead. The short version: a quoted price that excludes the consultation, the prescription review, or the clinical aftercare is a quote for less than you actually need.

What makes a Mounjaro supplier genuinely good

Three things: regulatory standing, clinical process, and supply chain integrity. On the regulatory side, any pharmacy legally dispensing Mounjaro must be registered with the General Pharmaceutical Council. You can check the GPhC premises register directly, the registration number is searchable in seconds. If it isn't there, move on. For reference, nume's GPhC registration is 9012878, verifiable at the GPhC register.

Clinical process is where the real difference between suppliers emerges. Tirzepatide is not a straightforward over-the-counter product. A genuine supplier will require a clinical questionnaire, check your BMI using live weight verification rather than self-reported numbers, confirm your identity with photo ID, and have a GPhC-registered Independent Prescriber personally review your case before anything is approved or dispensed. At nume, that review happens the same day, a real clinician reads your answers, not a piece of software. GP notification is also carried out in line with GPhC guidance, and every repeat order gets the same scrutiny as the first.

Supply chain integrity means the pens come from Eli Lilly's authorised UK distribution network. Genuine Mounjaro KwikPens are pre-filled devices, consistently marked, and arrive cold-chain packaged. Store yours in the fridge as soon as it arrives (most people keep it in the fridge door) and consult the Patient Information Leaflet for the exact room-temperature window if you need to take it out. Never accept pens in unlabelled packaging or without a pharmacy dispensing label.

Switching supplier: what the clinical handover looks like

If you are already on Mounjaro and want to change supplier, the process has a few more steps than starting fresh. A responsible new supplier will ask for evidence of your current dose before agreeing to continue at that level. This isn't bureaucracy for its own sake, it's what the clinical handover for switching your Mounjaro supplier is designed to protect you from. Dispensing a higher dose than someone has been titrated to carries real risk, and any supplier that skips the evidence check should make you uncomfortable rather than grateful.

Your prescriber at the new pharmacy should review your history, confirm the dose is appropriate, and assess whether anything in your circumstances has changed. At nume, transfer patients are asked to share evidence of current treatment and go through the same same-day clinical review as new patients. There are no shortcuts on dose increases either, clinical evidence is required before any step up. The NHS England guidance on weight-management injections sets out the standards all providers should be meeting around clinical oversight and wrap-around care, and it is worth reading if you want to understand what good looks like.

It is also worth thinking about what ongoing support your supplier offers between orders. Access to clinical advice when a side effect feels worse than expected, or when you are unsure whether to delay a dose, is part of what responsible dispensing looks like. Common questions our team fields give a sense of the kind of aftercare that should be standard.

Eligibility: the clinical baseline any supplier must apply

No legitimate supplier can offer Mounjaro to everyone who wants it, and the ones that claim otherwise are a red flag. The licensed criteria, per the Mounjaro Summary of Product Characteristics, require a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, raised cholesterol, type 2 diabetes, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. A BMI figure alone is never the whole picture; the prescriber weighs up the full clinical assessment.

If you want to think through whether treatment is likely to be suitable before filling in a form, our weight-loss treatment overview explains the options in plain terms. Details about how your appetite responds to treatment, the role of what you eat, and whether certain foods work better alongside tirzepatide are all questions that come up naturally once treatment starts, and our prescribers are on hand to answer them. Practical questions about where to inject Mounjaro for the best appetite suppression and guidance on which supplements are worth taking alongside Mounjaro are also covered in our clinical resources. When you are ready, you can check your eligibility with a free consultation; a prescriber reviews it the same day.